Author:
Angarita Fernando A,Rodríguez Jorge L,Meek Eugenio,Sánchez Jesus O,Tawil Mauricio,Torregrosa Lilian
Abstract
Abstract
Background
Primary neuroendocrine carcinoma of the breast is a heterogeneous group of rare tumors with positive immunoreactivity to neuroendocrine markers in at least 50% of cells. Diagnosis also requires that other primary sites be ruled out and that the same tumor show histological evidence of a breast in situ component. Primary neuroendocrine carcinoma of the breast rarely presents as locally advanced disease and less frequently with such widespread metastatic disease as described herein. The review accompanying this case report is the first to provide an overview of all the cases of primary neuroendocrine carcinoma of the breast published in the literature and encompasses detailed information regarding epidemiology, histogenesis, clinical and histologic diagnosis criteria, classification, surgical and adjuvant treatment, as well as prognosis. We also provide recommendations for common clinical and histologic pitfalls associated with this tumor.
Case presentation
We describe a case of a 51-year-old Hispanic woman initially diagnosed with locally-advanced invasive ductal carcinoma that did not respond to neodjuvant treatment. After undergoing modified radical mastectomy the final surgical pathology showed evidence of alveolar-type primary neuroendocrine carcinoma of the breast. The patient was treated with cisplatin/etoposide followed by paclitaxel/carboplatinum. Thirteen months after surgery the patient is alive, but developed pulmonary, bone, and hepatic metastasis.
Conclusion
The breast in situ component of primary neuroendocrine carcinoma of the breast may prevail on a core biopsy samples increasing the probability of underdiagnosing this tumor preoperatively. Being aware of the existence of this disease allows for timely diagnosis and management. Optimal treatment requires simultaneous consideration of both the neuroendocrine and breast in situ tumor features.
Publisher
Springer Science and Business Media LLC
Reference73 articles.
1. Feyrter F, Harmann G: On the carcinoid growth form of the carcinoma mammae, especially the carcinoma solidum (gelatinosum) mammae (in German). Frankf Z Pathol. 1963, 73: 24-39.
2. Cubilla AL, Woodfruff JM: Primary carcinoid tumor of the breast: a report of eight patients. Am Surg Pathol. 1977, 1: 283-10.1097/00000478-197712000-00001.
3. Sapino A, Righi L, Cassoni P, Pietribiasi F, Bussolati G: Expression of the neuroendocrine phenotype in carcinomas of the breast. Semin Diagn Pathol. 2000, 17: 127-137.
4. Bussolati G, Gugliotta P, Sapino A, Eusebi V, Lloyd RV: Chromogranin-reactive endocrine cells in argyrophilic carcinomas (“carcinoids”) and normal tissue of the breast. Am J Pathol. 1985, 120: 186-192.
5. Azzopardi JG, Muretto P, Goddeeris P, Eusebi V, Lauweryns JM: ‘Carcinoid’ tumours of the breast: the morphological spectrum of argyrophil carcinomas. Histopathology. 1982, 6: 549-569. 10.1111/j.1365-2559.1982.tb02750.x.
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献